Updated:
CELLCYTE GENETICS CORP
CELLCYTE GENETICS CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001325279, and its reported industry...
Overview
CELLCYTE GENETICS CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001325279, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-04-15, it reported net income of USD -164,038; total assets of USD 9,033 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CELLCYTE GENETICS CORP
- Former names in filing history
- Shepard Inc. (2005-05-04 to 2007-02-22)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Bellevue, WA, United States
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001325279
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Operating cash flow |
|---|---|---|---|---|
| FY2013USD | -$164,038 | $9,033 | -$62,658 | |
| FY2012USD | $585,827 | $25,621 | -$78,372 | |
| FY2011USD | — | $39,406 | -$144,304 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 10-Q | 10Q | ||
| 10-Q | 10-Q | ||
| 10-K | 10-K | ||
| 10-Q | 10Q | ||
| 8-K | 8K | ||
| 10-Q | 10Q | ||
| 10-Q | 10Q | ||
| 10-K | 10K | ||
| 10-Q | 10Q | ||
| 10-Q | 10-Q | ||
| 10-Q | 10Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CELLCYTE GENETICS CORP in Altss
Track this company’s investors, transactions and relationships in Altss.